The Breast Cancer Research Foundation of Alabama (BCRFA) announces a continued commitment to advancing breast cancer research in 2025 with an impressive $1,200,000 investment.
The Breast Cancer Research Foundation of Alabama (BCRFA) enthusiastically announces its continued dedication to support breast cancer research in Alabama through a significant investment of $1,125,000 in 2024.
The BCRFA today announced its investment of $1.25M to power breast cancer research across Alabama. From breakthroughs in early detection to prevention treatments, these grants will fund 35 innovative projects at 8 partner institutes and ultimately help save lives.
Auburn scientist Dr. Gary Piazza is putting a new experimental compound to the test against the most aggressive forms of cancer, including triple negative breast cancer (TNBC).
With BCRFA funding, Auburn University researchers are developing novel treatments for triple-negative breast cancer and overcoming drug resistance in breast cancer cells.
A team of researchers in the Auburn University College of Veterinary Medicine is working to identify and study genetic factors associated with hereditary breast cancer in the African American community.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.